Development and Clinical Status of Cytomegalovirus Vaccines
- 1 July 1994
- journal article
- research article
- Published by Springer Nature in Clinical Immunotherapeutics
- Vol. 2 (1) , 1-6
- https://doi.org/10.1007/bf03258516
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody StatusNew England Journal of Medicine, 1992
- Effect of Towne Live Virus Vaccine on Cytomegalovirus Disease after Renal TransplantAnnals of Internal Medicine, 1991
- The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitopeJournal of General Virology, 1990
- Progress in Vaccine Development for Prevention of Human Cytomegalovirus InfectionPublished by Springer Nature ,1990
- Effectiveness and Cost Benefit of a Proposed Live Cytomegalovirus Vaccine in the Prevention of Congenital DiseaseClinical Infectious Diseases, 1990
- Protective Effects of Towne Cytomegalovirus Vaccine Against Low-Passage Cytomegalovirus Administered as a ChallengeThe Journal of Infectious Diseases, 1989
- Molecular epidemiology of cytomegalovirus in a nursery: Lack of evidence for nosocomial transmissionThe Journal of Pediatrics, 1986
- Cytomegalovirus infections in neonates acquired by blood transfusionsThe Pediatric Infectious Disease Journal, 1983
- Cytomegalovirus Infections Following Renal TransplantationClinical Infectious Diseases, 1981
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981